Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
QuantuMDx logo — Transforming Point of Need Multiplex Diagnostics

QuantuMDx

Transforming Point of Need Multiplex Diagnostics

Founded 2008 United Kingdom Newcastle Upon Tyne, United Kingdom 59 employees Series Unknown Total: $59.77M Biotechnology, Health Care +1

General Information

Company Name QuantuMDx
Founded Year 2008
Location United Kingdom Newcastle Upon Tyne, United Kingdom +2
Employees 59
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when QuantuMDx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About QuantuMDx

QuantuMDx, founded in 2008, is a forward-thinking MedTech company headquartered in the United Kingdom. With a commitment to innovation in the fields of Biotechnology, Health Care, and Pharmaceutical, the company is dedicated to advancing multiplex molecular diagnostic solutions under its slogan, "Transforming Point of Need Multiplex Diagnostics."

QuantuMDx leverages leading-edge technology to produce diagnostic tools designed for immediate application at the point of need, which aligns with current market trends favoring rapid diagnostics. Their approach positions them uniquely in a competitive field, fostering potential disruptive impact within healthcare delivery systems globally.

The company last secured a £15.00M Venture Round of investment on 08 November 2021 from the Vita Spring IVD Fund. This financing underscores investor confidence in QuantuMDx's mission and innovative capability.

Taxonomy: MedTech, Molecular Diagnostics, Point of Need Diagnostics, Hand-held Diagnostic Devices, Low Cost Diagnostics, Genomic Sequencing, Personalised Medicine, Portable Diagnostic Platforms, COVID-19 Diagnostics, DNA Extraction, Rapid Diagnostics, Respiratory Infections, Sexually Transmitted Infections, In Vitro Diagnostics, Assay Development

Services & Products

Rapid Multiplex PCR Testing
Point-of-Care Diagnostic Devices
Development of Diagnostic Assays
Healthcare and Laboratory Solutions

Target Customers

Healthcare Professionals Clinical Setting Managers Laboratory Professionals Testing Providers

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 08 Nov 2021
Debt Financing •••••• 1 •••• •••• 24 Mar 2021
Debt Financing •••••• - 27 Jan 2020
Venture Round •••••• 1
Investor
01 Nov 2017
Venture Round •••••• 1
Investor
01 Jun 2017

View All 12 Funding Rounds

QuantuMDx Alternatives & Competitors

View All Alternatives
QuantuMDx vs
QSM Diagnostics, Inc
QSM Diagnostics, Inc United States

Infection Detection Redefined.

Series Unknown
17 employees
Health Care, Medical Devices
Compare QuantuMDx vs QSM Diagnostics, Inc
QuantuMDx vs
HelixBind, Inc
HelixBind, Inc United States

Revolutionizing care for invasive infections such as sepsis

Grant
32 employees
Biotechnology, Medical Devices
Compare QuantuMDx vs HelixBind, Inc
QuantuMDx vs
Nanosphere
Nanosphere United States

Nanosphere is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that...

Post Ipo Debt
41 employees
Biotechnology, Health Care
Compare QuantuMDx vs Nanosphere
View all alternatives

FAQ About QuantuMDx

Transforming Point of Need Multiplex Diagnostics
QuantuMDx was founded in 2008.
QuantuMDx is headquartered in Newcastle Upon Tyne, United Kingdom.
QuantuMDx operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
QuantuMDx has approximately 59 employees.
QuantuMDx has completed 12 funding rounds, raising a total of $59.77M. The latest funding stage is Series Unknown.
QuantuMDx offers: Rapid Multiplex PCR Testing, Point-of-Care Diagnostic Devices, Development of Diagnostic Assays, Healthcare and Laboratory Solutions.
Top alternatives and competitors to QuantuMDx include QSM Diagnostics, Inc, HelixBind, Inc, Nanosphere, BioNanovations, Visby Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QuantuMDx and QSM Diagnostics, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors QuantuMDx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy